Lundbeck sites
Contact Us
About Azilect
Key publications
For your patients
Prescribing information
Azilect
®
– a well tolerated therapy
Azilect – a well tolerated therapy for early and advanced Parkinson's disease patients.
Parkinson’s disease animations
View the animations to learn more about Parkinson's disease. They can be helpful in communicating with your patients.
Azilect® – treating the symptoms of Parkinson's disease
Want to know more about Azilect?
Azilect has demonstrated efficacy in 4 large clinical trials, both as monotherapy (TEMPO, ADAGIO) and as an adjunct to levodopa in Parkinson's disease patients (PRESTO, LARGO).
ADAGIO trial results show Azilect® slows clinical progression of Parkinson’s disease
The ADAGIO study showed that Parkinson's disease patients who took Azilect® (rasagiline) 1mg tablets once-daily upon entry into the trial, demonstrated a significant improvement...